ArticlePLoS computational biology2026
CA-CAE: A deep learning-based multi-omics model for pan-cancer subtype classification and prognosis prediction.
Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Deep learning multi-omics integration identifies new molecular subtypes of lung cancer.BioData mining · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In cancer research, identifying cancer subtypes and evaluating prognosis are crucial for personalized diagnosis and treatment of cancer. With the advancement of high-throughput sequencing technologies, multi-omics data has become essential for cancer classification and prognostic analysis. By integrating deep learning techniques, it is possible to more accurately identify cancer subtypes, providing a robust basis for personalized treatment of cancer patients. In this study, we propose a convolutional autoencoder prognostic model incorporating a channel attention mechanism (CA-CAE). The model utilizes multi-omics data to predict survival-associated cancer subtypes and identify prognostic genes. We applied CA-CAE to multiple cancer types, successfully identifying subtypes in 15 distinct cancer types and revealing significant survival differences among these subtypes. Moreover, compared to traditional statistical methods and other deep learning approaches, CA-CAE demonstrated superior performance in predicting survival outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.